Who backs Crossbow Therapeutics?
13 investors| Investor | Type |
|---|---|
| Mirae Asset Capital | Venture capital |
| Arkin Capital | Family office |
| Pfizer Ventures | Other |
| Eli Lilly and Company Foundation | Other |
| MPM BioImpact | Venture capital |
| BVF Partners | — |
| Hamilton Square Partners Management | — |
| Libbs | — |
| LifeLink Ventures | — |
| Mirae Asset Venture Investment | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Crossbow Therapeutics investors
13 investors are on record for Crossbow Therapeutics, including Mirae Asset Capital, Arkin Capital, Pfizer Ventures and Eli Lilly and Company Foundation. The early-stage round in Sep 2025 drew 17 investors.
Free account
More of Crossbow Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Crossbow Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Crossbow Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View